Researchers have developed a comprehensive resource, named IBDverse, utilizing single-cell RNA sequencing (scRNA-seq) to analyze over 1.1 million cells from terminal ileal biopsies. The study involved 111 patients diagnosed with Crohn’s disease (CD) and 232 healthy individuals, aiming to uncover the molecular underpinnings of this chronic inflammatory bowel disease (IBD).
Identifying Crohn’s Disease Signatures
The findings highlight specific epithelial and immune cell changes that are characteristic of Crohn’s disease. Epithelial cells exhibited an upregulation of interferon-driven major histocompatibility complex class I molecules, a change that persisted even in progenitor cells after visible inflammation had resolved. The study also identified ITGA4+ macrophages as significant drivers of inflammation, showing increased activity in pathways such as JAK-STAT signaling and elevated expression of key cytokines like interleukin-6 (IL-6), IL-12, and IL-23.
Furthermore, heritability analysis linked inflammatory monocytes and macrophages to susceptibility for Crohn’s disease, suggesting a crucial role for both resident and recruited immune cells in the disease’s development. This comprehensive cellular and molecular framework provides a deeper understanding of CD’s complex mechanisms and points toward potential new therapeutic avenues.
A Large-Scale Resource for IBD Research
Crohn’s disease is characterized by its significant heterogeneity in how it presents clinically and how patients respond to treatment. Despite advances in therapies targeting specific cytokines, a substantial number of patients experience non-response or secondary loss of response, leading to a continuous need for better understanding of the disease’s etiology. Single-cell RNA sequencing offers a high-resolution approach to dissect complex tissues.
The IBDverse resource, comprising data from 343 individuals, was designed to overcome limitations of previous studies, which were often constrained by smaller sample sizes. By integrating discovery and replication cohorts, the study aimed for robust identification of CD-associated cell types, genes, and pathways. The data was collected from terminal ileal biopsies, with patients with CD being, on average, younger than healthy controls.
Key Cell Types and Gene Expression
Analysis revealed 57 distinct cell clusters within the terminal ileal biopsies, encompassing epithelial, immune, and mesenchymal compartments. Thirteen cell types were found to be significantly enriched in CD patients across both discovery and replication cohorts. Among these were S100A8/9+ monocytes and CXCL9/CXCL10+ macrophages, which were present in much higher proportions in inflamed CD biopsies compared to healthy controls.
The study also identified CD-specific enterocytes, including GPX2+ progenitor cells and IFI27+ villus cells, which displayed transcriptional signatures related to barrier response and antimicrobial activity. Genes such as CEACAM20, involved in sensing bacteria, and antimicrobial peptides, along with cytokine-responsive elements, were noted. The research indicates that the intestinal epithelium plays an active role in the inflammatory cascade, extending beyond its function as a simple physical barrier.
Differential gene expression analysis identified thousands of unique differentially expressed genes (DEGs) within CD samples compared to healthy controls. Secretory epithelial cells, enterocytes, and T cells showed the highest numbers of DEGs, highlighting their significant involvement in the disease process.
Mitchell Landsberg is the senior reporter for News Raise and focuses on Technology. Mitchell regularly writes about social media platforms and how influencers, industry and general people use them to communicate and make money.
